Examination of Nociscan Impact on Discogenic Low Back Pain Surgical Outcomes

Part of paid clinical trials in Beverly Hills, California.

Sponsor
Aclarion
Study ID
NCT06661850
Status
Recruiting

Conditions

  • Discogenic Low Back Pain

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Not accepted

Interventions

  • Fusion or TDR determined by investigator. — PROCEDURE
    The surgical treatment will be decided by the treating investigator based on their clinical judgement.

Study Details

This study is looking into how safe and useful NOCISCAN is. NOCISCAN is a software as a Service (SaaS) tool that uses Magnetic Resonance (MR) spectroscopy. Nociscan (instead of 'It') leverages MRS to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. The randomized controlled trial will compare the blinded and unblinded cohorts and their corresponding surgical outcomes with the Nocigram reports, generated prior to treatment, for each patient."

Key Dates

Start date
Jun 11, 2025
Status verified
May 2026
Primary completion
Sep 30, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
300 participants (estimated)

Arms

  • Arm: Blinded-to-NOCISCAN
    NOCISCAN completed pre-operatively. Investigator will not have access to NOCISCAN result.
  • Arm: Unblinded-to-NOCISCAN
    NOCISCAN completed pre-operatively. Investigator will have access to the NOCISCAN result after completing initial treatment plan but before treatment.

Primary Outcome Measure

Change in back pain on 100mm Visual Analog Scale (VAS) Pain Assessment [ Time Frame: Baseline to 12 months ]

Central Contacts

Locations (8)

FacilityCityStateZIPSite coordinators
Todd H. Lanman, M.D IncBeverly HillsCalifornia90210
Nicole Phillips
310-385-7766
Todd Lanman, MD (PRINCIPAL_INVESTIGATOR)
Scripps HealthLa JollaCalifornia92037
Joy Biggers
858-554-5273
Hani Malone, MD (PRINCIPAL_INVESTIGATOR)
USC Keck Medical CenterLos AngelesCalifornia90033
Edgar Martinez Sanchez
323-442-5300
Patrick Hsieh, MD (PRINCIPAL_INVESTIGATOR)
University of Miami/ Jackson Health SystemMiamiFlorida33136
Adriana Saravia
305-243-3048
Gregory Basil, MD (PRINCIPAL_INVESTIGATOR)
Northwestern UniversityChicagoIllinois60611
Lidia Hrvojevic
312-695-4463
Alpesh Patel, MD (PRINCIPAL_INVESTIGATOR)
Advocate Aurora Research InstitutePark RidgeIllinois60068
Victor Arroyo
847-723-7950
Patrick Sugrue, MD (PRINCIPAL_INVESTIGATOR)
Johns Hopkins MedicineBaltimoreMaryland21287
Daniel Davidar
6673067925
Daniel Lubelski, MD (PRINCIPAL_INVESTIGATOR)
Texas Back InstitutePlanoTexas75093
Shannon Rusch
972-608-5181
Alexander Satin, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Beverly Hills, CA

Related Studies